Prescribers should consult the section Patients with Renal Impairment (Section 4.2) for recommendations on dosing and administration in this patient group.
Annustamise ja manustamise soovitused sellele patsientide grupile vt Neerupuudulikkusega patsiendid (lõik 4. 2).